Novo Nordisk to cap insulin prices in Minnesota settlement
Novo Nordisk’s Ozempic Gets FDA Approval
Danish businesses are concerned about a possible trade conflict with the United States over Greenland, a major lobby group ...
J.P. Morgan analyst Richard Vosser maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of ...
Denmark’s Novo Nordisk saw its shares rise as much as 13% to 659.20 kroner this morning, after it announced top-line results ...
New York Post on MSN13d
Denmark’s prime minister speaks to business leaders following Trump’s Greenland threatDenmark is home to companies such as drugmaker Novo Nordisk, shipping group Maersk, brewer Carlsberg, toymaker Lego, ...
Amycretin could give Novo a buzzy product in a newly competitive obesity market. It works similarly to existing GLP-1 ...
The Atlantic on MSN8d
Trump Triggers a Crisis in Denmark—And Europe"Trump might forget about Greenland. But also, he might not. Nobody knows. He operates on whims," @anneapplebaum writes.
In a report released today, Jo Walton from UBS maintained a Buy rating on Novo Nordisk (0QIU – Research Report), with a price target of ...
Novo Nordisk today announced topline results from a phase 1b/2a clinical trial with amycretin, a unimolecular GLP-1 and ...
Stocks to Buy or Sell. In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback